Evaluation of efficacy to combine transarterial chemoembolization and intrahepatic arterial infusion of DDP-H for hepatocellular carcinoma
Phase 2
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000002428
- Lead Sponsor
- iigata Hepatocellular Carcinoma Therapy Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1)Severe allergic history for iodine and platinum drug 2)Pregnant, possibility of pregnancy, or feeding a baby 3)Vascular involvement Vp3, Vv3 or more 4)Under interferon therapy 5)Other factors that a responsible doctor judged to be unsuitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method